Octreotide

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis

Pain / Clinical Trial / Statistical Analysis / Randomization / Pharmacokinetics / Treatment Outcome / Pancreatitis / Prevention / Somatostatin / Humans / Pancreas / Hormones / Statistical Significance / Acute Pancreatitis / Cost effectiveness / Metaanalysis / Randomized Trial / Meta Analysis / Publication Bias / Clinical Sciences / Gastrointestinal Endoscopy / Gastrointestinal / Endoscopic Retrograde Cholangiopancreatography / Acute Disease / Outcome measure / Adverse effect / Octreotide / Treatment Outcome / Pancreatitis / Prevention / Somatostatin / Humans / Pancreas / Hormones / Statistical Significance / Acute Pancreatitis / Cost effectiveness / Metaanalysis / Randomized Trial / Meta Analysis / Publication Bias / Clinical Sciences / Gastrointestinal Endoscopy / Gastrointestinal / Endoscopic Retrograde Cholangiopancreatography / Acute Disease / Outcome measure / Adverse effect / Octreotide